Chinese gene sequencing developer Axbio closes Series B round at nearly $100m

Shenzhen-based Axbio on Monday announced the completion of a Series B funding round at close to $100 million as the startup looks to advance its next-generation sequencing technology and build its first good manufacturing practice (GMP)  factory.